Literature DB >> 26497444

Verteporfin photodynamic therapy for the treatment of sporadic retinal capillary haemangioblastoma.

R N Hussain1, F Jmor2, B Damato3, H Heimann2.   

Abstract

PURPOSE: To assess the effectivity of photodynamic therapy (PDT) for the treatment of retinal capillary haemangiomas
METHOD: Retrospective case note analysis of all patients with retinal angiomas treated with PDT between 2003 and 2010.
RESULTS: Six eyes of 6 patients (3 male, 3 female) with a mean age of 50 years (range, 23-78) were identified in our database. The follow up period was between 24 and 60 months (mean, 36). Tumor regression was evident in two patients; three tumors showed no demonstrable response to treatment on ophthalmoscopy or ultrasonography and one tumor progressed despite PDT and subsequent cryotherapy. One patient developed retinal neovascularisations following a period of inattendence to our clinic. Visual acuity improved in two patients following PDT, deteriorated in three patients and remained stable in a one patient.
CONCLUSION: The response of retinal haemangioblastomas to PDT is inconsistent. Other treatment modalities ought to be utilized for peripheral lesions, however PDT may be tried in juxtapapillary lesions where radiotherapy or cryotherapy is likely to result in concurrent visual loss.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  PDT; Retinal capillary haemangioblastoma; Von Hippel–Landau

Mesh:

Substances:

Year:  2015        PMID: 26497444     DOI: 10.1016/j.pdpdt.2015.10.008

Source DB:  PubMed          Journal:  Photodiagnosis Photodyn Ther        ISSN: 1572-1000            Impact factor:   3.631


  6 in total

1.  Longitudinal Swept-Source OCT Angiography of Juxtapapillary Retinal Capillary Hemangioblastoma.

Authors:  Jonathan F Russell; Yingying Shi; Giovanni Gregori; Philip J Rosenfeld
Journal:  Ophthalmol Retina       Date:  2020-05-08

Review 2.  [Retinal tumors in adults - Part 1: vascular tumors of the retina].

Authors:  Roya Piria; Felix Rommel; Michael Zimbelmann; Kristina Erikson; Neele Babst; Anton Brosig; Josephine Christin Freitag; Mahdy Ranjbar; Salvatore Grisanti; Vinodh Kakkassery
Journal:  Ophthalmologe       Date:  2021-07-26       Impact factor: 1.059

3.  Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.

Authors:  Virginia Albiñana; Rosa María Jiménez Escribano; Isabel Soler; Luis Rodríguez Padial; Lucia Recio-Poveda; Karina Villar Gómez de Las Heras; Luisa María Botella
Journal:  Orphanet J Rare Dis       Date:  2017-06-29       Impact factor: 4.123

Review 4.  Von Hippel-Lindau Disease and the Eye.

Authors:  Saeed Karimi; Amir Arabi; Toktam Shahraki; Sare Safi
Journal:  J Ophthalmic Vis Res       Date:  2020-02-02

Review 5.  Ocular Manifestations of von Hippel-Lindau Disease.

Authors:  Misty D Ruppert; Meredith Gavin; Kelly T Mitchell; Alan N Peiris
Journal:  Cureus       Date:  2019-08-04

6.  Laser photocoagulation, intravitreal anti-VEGF, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma.

Authors:  Gamze Ucan Gunduz; Oner Gelisken; Ozgur Yalcinbayir; Kazim Guler
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.